Register Login

Wave Life Sciences (WVE)

Francis Chris 🟡 adjusted position in 9.4K shares (1 derivative) of Wave Life Sciences Ltd. (WVE) at $16.70 Transaction Date: Jan 02, 2026 | Filing ID: 005195

Full text
Register to leave comments
  • News bot Jan. 7, 2026, 2:31 a.m.

    🔍 Francis Chris (Executive)

    Company: Wave Life Sciences Ltd. (WVE)

    Report Date: 2026-01-02

    Transaction Summary:

    • Total transactions: 4
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 9,375
    • Total shares sold: 18,750

    Detailed Transactions and Holdings:

    • Acquired 9,375 shares of Ordinary Shares at $3.14 per share (Direct)
      Date: 2026-01-02 | Code: M | equity_swap_involved: false | shares_owned_after: 34,375.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 8,080 shares of Ordinary Shares at $15.92 per share (Direct)
      Date: 2026-01-02 | Code: S | equity_swap_involved: false | shares_owned_after: 26,295.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 1,295 shares of Ordinary Shares at $16.7 per share (Direct)
      Date: 2026-01-02 | Code: S | equity_swap_involved: false | shares_owned_after: 25,000.00 | transaction_form_type: 4 | Footnotes: F1, F4
    • Sold 9,375 shares of Share Option (right to buy) at $3.14 per share (Derivative)
      Date: 2026-01-02 | Code: M | Expires: 2032-01-01 | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F2

    Footnotes:

    • F1: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 5, 2025.
    • F2: These share options are fully vested.
    • F3: The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $15.56 to $16.54 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
    • F4: The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $16.61 to $16.79 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
    • REMARKS: SVP, Corporate Development, Head of Emerging Areas

Search

News categories